RCES study materials
RCES study resources

Apnea During Sedation for Cardioversion in a Low-EF Patient

RCES · Put your knowledge to work in context.

All case studies

Apnea During Sedation for Cardioversion in a Low-EF Patient

A 76-year-old woman (68 kg) with persistent AF, EF 30%, and CrCl 34 mL/min is on amiodarone 200 mg daily, apixaban, and furosemide. She presents for an elective TEE-guided cardioversion. Baseline BP is 118/70, HR 96, SpO2 95% on room air. Over 20 minutes she receives midazolam 5 mg and fentanyl 100 mcg in 1-2 mg/25 mcg increments. She becomes unresponsive to voice, with a respiratory rate of 5/min, SpO2 86% on 4 L nasal cannula, BP 88/54, and a capnography waveform that is low-amplitude and consistent with hypoventilation. The TEE probe has not yet been inserted.

1. Give your immediate management, including whether you would reverse and with which agent and dose. Justify your choice.

Read the worked answer

Airway first, drugs second. Call for help, perform a jaw thrust and chin lift, suction if needed, insert an oral airway, and ventilate with a bag-valve-mask and 100% oxygen while watching the capnography trace and SpO2. If ventilation is restored with a simple maneuver, no reversal is required.

If hypoventilation persists:

  • Naloxone 0.04-0.1 mg IV, titrated every 2 minutes. Do not give a 0.4 mg bolus: abrupt reversal causes pain, a catecholamine surge, hypertension, tachycardia, and pulmonary edema - poorly tolerated with an EF of 30%.
  • Flumazenil 0.2 mg IV only if benzodiazepine effect clearly dominates. It can precipitate seizures in chronic benzodiazepine users, and its half-life is shorter than midazolam's, so resedation must be watched for.
  • Because both classes were given, ventilation is the primary therapy; reversal is reserved for persistent respiratory depression after airway support.

For the hypotension: supine position with legs elevated, a 250-500 mL crystalloid bolus, and reassessment after oxygenation improves - hypoxia and the sedatives are both contributing.

2. Why did this patient respond so profoundly, and how would you adjust for a future procedure?

Read the worked answer

Contributors, all additive:

  • Age and low EF - increased sensitivity to both agents and blunted hemodynamic reserve.
  • CrCl 34 mL/min - accumulation of alpha-1-hydroxymidazolam glucuronide, an active metabolite that prolongs sedation.
  • Amiodarone - inhibits CYP3A4 (raising midazolam levels) and P-glycoprotein, and was taken that morning.
  • Opioid-benzodiazepine synergy - the combination produces far more respiratory depression than either drug alone.

Adjustments for next time:

  • Start much smaller: midazolam 0.5-1 mg or fentanyl 12.5-25 mcg, then wait 3-5 minutes before adding, rather than stacking doses.
  • Consider etomidate for a short cardioversion - hemodynamically neutral and short-acting - or a carefully titrated propofol bolus with anesthesia support.
  • Capnography from the start, oxygen by cannula, and a pre-procedure anesthesia consultation given the EF and renal function.
  • Reassess the need to hold or reduce home amiodarone on the day of the procedure with the prescribing physician.

3. What monitoring and staffing standards should have been in place for this sedation, and what documentation matters afterward?

Read the worked answer

Standards for moderate sedation in the EP lab:

  • A qualified provider ordering and titrating the sedation, and a dedicated observer whose only job is monitoring the patient - not the scrub tech, not the circulator, and not the person performing the TEE.
  • Continuous ECG, SpO2, and capnography, with BP and respiratory rate at least every 5 minutes; supplemental oxygen and suction immediately available.
  • Pre-procedure assessment documented: airway exam, ASA class, NPO status, medication list including amiodarone, renal function, and baseline vitals.
  • Airway equipment, bag-valve-mask, reversal agents, and a code cart checked and in the room.

Documentation after the event: drugs and doses with times, the time and nature of the deterioration, the interventions and their effect, the reversal agent used if any, vital signs through recovery, the notification of the attending, and a note that this alters the plan for any future sedation. Report it through the appropriate event-reporting pathway rather than only in the procedure note.